Assessment of bone mass change by DXA vs. DXR in postmenopausal women treated with alendronate

被引：0
|
作者：
Galesanu, C
Galesanu, RG
机构：
[1] Univ Med & Pharm, Iasi, Romania
[2] Ctr Imaging & Radiol Diagnosis, Iasi, Romania
来源：
BONE | 2005年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S317 / S317
页数：1
相关论文
共 50 条
  • [1] Changes in Lumbar Spine QCT, DXA, and TBS in Postmenopausal Women With Low Bone Mass Treated With Denosumab, Alendronate, or Placebo
    Thomas, Thierry
    Cheung, Angela M.
    Shane, Elizabeth
    Zanchetta, Jose R.
    Kearns, Ann
    Hans, Didier
    Lin, Celia J. F.
    Austin, Matthew
    Libanati, Cesar
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [2] Impact of alfacalcidol on bone mineral density (pQCT & DXA) of radius, tibia, spine and hip in postmenopausal alendronate treated women with reduced bone mass
    Felsenberg, D.
    Bock, O.
    Boerst, H.
    Armbrecht, G.
    Beller, G.
    Degner, C.
    Schacht, E.
    Mazor, Z.
    Hashimoto, J.
    Martus, P.
    Runge, M.
    [J]. BONE, 2009, 44 : S37 - S38
  • [3] Using in postmenopausal women with bone mass loss raloxifene and alendronate
    Bazarra, A
    Castro, A
    Suarez, M
    [J]. OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S172 - S172
  • [4] Additive impact of alfacalcidol on bone mineral density and bone strength in alendronate treated postmenopausal women with reduced bone mass
    Felsenberg, D.
    Bock, O.
    Boerst, H.
    Armbrecht, G.
    Beller, G.
    Degner, C.
    Stephan-Oelkers, M.
    Schacht, E.
    Mazor, Z.
    Hashimoto, J.
    Roth, H-J.
    Martus, P.
    Runge, M.
    [J]. JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS, 2011, 11 (01) : 34 - 45
  • [5] ASSESSMENT OF BONE MASS IN POSTMENOPAUSAL WOMEN
    Nikolov, M.
    Nikolov, N.
    Kirilova, E.
    Kirilov, N.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S436 - S437
  • [6] Spectroscopic markers of bone quality in alendronate-treated postmenopausal women
    Boskey, A. L.
    Spevak, L.
    Weinstein, R. S.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2009, 20 (05) : 793 - 800
  • [7] Spectroscopic markers of bone quality in alendronate-treated postmenopausal women
    A. L. Boskey
    L. Spevak
    R. S. Weinstein
    [J]. Osteoporosis International, 2009, 20 : 793 - 800
  • [8] Teriparatide improves bone microarchitecture in postmenopausal women previously treated with alendronate
    Li, J.
    Burr, D. B.
    Stepan, J. J.
    Dobnig, H.
    Fahrleitner-Pammer, A.
    Sipos, A.
    Mullamey, T.
    Westmore, M.
    Sato, M.
    Pavo, I.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S28 - S28
  • [9] Treatment with 5 mg alendronate in postmenopausal women with low bone mass
    Moggia, S
    Sayegh, F
    Otero, A
    Man, Z
    [J]. RECENT RESEARCH IN GYNECOLOGICAL ENDOCRINOLOGY, 2001, : 225 - 226
  • [10] Assessment of Fracture Risk and Treatment of Osteoporosis in Postmenopausal Women: Bone Density vs. BONE DESTINY©
    Beattie, Karen A.
    Bensen, William G.
    Larche, Maggie
    Papaioannou, Alexandra
    Pack, William Wong
    Adachi, Jonathan D.
    [J]. JOURNAL OF RHEUMATOLOGY, 2009, 36 (11) : 2562 - 2562
12345